Cargando…

The FAT expandability (FATe) Project: Biomarkers to determine the limit of expansion and the complications of obesity

BACKGROUND: Obesity is an excessive accumulation of fat frequently, but not always, associated with health problems, mainly type 2 diabetes and cardiovascular disease. During a positive energy balance, as caused by excessive intake or sedentary lifestyle, subcutaneous adipose tissue expands and accu...

Descripción completa

Detalles Bibliográficos
Autores principales: Torres-Perez, Elena, Valero, Monica, Garcia-Rodriguez, Beatriz, Gonzalez-Irazabal, Yolanda, Calmarza, Pilar, Calvo-Ruata, Luisa, Ortega, Carmen, Garcia-Sobreviela, Maria Pilar, Sanz-Paris, Alejandro, Artigas, Jose Maria, Lagos, Javier, Arbones-Mainar, Jose M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409987/
https://www.ncbi.nlm.nih.gov/pubmed/25896263
http://dx.doi.org/10.1186/s12933-015-0203-6
_version_ 1782368261690621952
author Torres-Perez, Elena
Valero, Monica
Garcia-Rodriguez, Beatriz
Gonzalez-Irazabal, Yolanda
Calmarza, Pilar
Calvo-Ruata, Luisa
Ortega, Carmen
Garcia-Sobreviela, Maria Pilar
Sanz-Paris, Alejandro
Artigas, Jose Maria
Lagos, Javier
Arbones-Mainar, Jose M
author_facet Torres-Perez, Elena
Valero, Monica
Garcia-Rodriguez, Beatriz
Gonzalez-Irazabal, Yolanda
Calmarza, Pilar
Calvo-Ruata, Luisa
Ortega, Carmen
Garcia-Sobreviela, Maria Pilar
Sanz-Paris, Alejandro
Artigas, Jose Maria
Lagos, Javier
Arbones-Mainar, Jose M
author_sort Torres-Perez, Elena
collection PubMed
description BACKGROUND: Obesity is an excessive accumulation of fat frequently, but not always, associated with health problems, mainly type 2 diabetes and cardiovascular disease. During a positive energy balance, as caused by excessive intake or sedentary lifestyle, subcutaneous adipose tissue expands and accumulates lipids as triglycerides. However, the amount of adipose tissue per se is unlikely to be the factor linking obesity and metabolic complications. The expandability hypothesis states that, if this positive energy balance is prolonged, a point is eventually reached where subcutaneous adipose tissue can not further expand and energy surplus no longer can be safely stored. Once the limit on storage capacity has been exceeded, the dietary lipids start spilling and accumulate ectopically in other organs (omentum, liver, muscle, pancreas) forming lipid byproducts toxic to cells. METHODS/DESIGN: FATe is a multidisciplinary clinical project aimed to fill gaps that still exist in the expandability hypothesis. Imaging techniques (CT-scan), metabolomics, and transcriptomics will be used to identify the factors that set the limit expansion of subcutaneous adipose tissue in a cohort of caucasian individuals with varying degrees of adiposity. Subsequently, a set of biomarkers that inform the individual limits of expandability will be developed using computational and mathematical modeling. A different validation cohort will be used to minimize the risk of false positive rates and increase biomarkers' predictive performance. DISCUSSION: The work proposed here will render a clinically useful screening method to predict which obese individuals will develop metabolic derangements, specially diabetes and cardiovascular disease. This study will also provide mechanistic evidence that promoting subcutaneous fat expansion might be a suitable therapy to reduce metabolic complications associated with positive energy balance characteristic of Westernized societies.
format Online
Article
Text
id pubmed-4409987
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44099872015-04-27 The FAT expandability (FATe) Project: Biomarkers to determine the limit of expansion and the complications of obesity Torres-Perez, Elena Valero, Monica Garcia-Rodriguez, Beatriz Gonzalez-Irazabal, Yolanda Calmarza, Pilar Calvo-Ruata, Luisa Ortega, Carmen Garcia-Sobreviela, Maria Pilar Sanz-Paris, Alejandro Artigas, Jose Maria Lagos, Javier Arbones-Mainar, Jose M Cardiovasc Diabetol Study Protocol BACKGROUND: Obesity is an excessive accumulation of fat frequently, but not always, associated with health problems, mainly type 2 diabetes and cardiovascular disease. During a positive energy balance, as caused by excessive intake or sedentary lifestyle, subcutaneous adipose tissue expands and accumulates lipids as triglycerides. However, the amount of adipose tissue per se is unlikely to be the factor linking obesity and metabolic complications. The expandability hypothesis states that, if this positive energy balance is prolonged, a point is eventually reached where subcutaneous adipose tissue can not further expand and energy surplus no longer can be safely stored. Once the limit on storage capacity has been exceeded, the dietary lipids start spilling and accumulate ectopically in other organs (omentum, liver, muscle, pancreas) forming lipid byproducts toxic to cells. METHODS/DESIGN: FATe is a multidisciplinary clinical project aimed to fill gaps that still exist in the expandability hypothesis. Imaging techniques (CT-scan), metabolomics, and transcriptomics will be used to identify the factors that set the limit expansion of subcutaneous adipose tissue in a cohort of caucasian individuals with varying degrees of adiposity. Subsequently, a set of biomarkers that inform the individual limits of expandability will be developed using computational and mathematical modeling. A different validation cohort will be used to minimize the risk of false positive rates and increase biomarkers' predictive performance. DISCUSSION: The work proposed here will render a clinically useful screening method to predict which obese individuals will develop metabolic derangements, specially diabetes and cardiovascular disease. This study will also provide mechanistic evidence that promoting subcutaneous fat expansion might be a suitable therapy to reduce metabolic complications associated with positive energy balance characteristic of Westernized societies. BioMed Central 2015-04-22 /pmc/articles/PMC4409987/ /pubmed/25896263 http://dx.doi.org/10.1186/s12933-015-0203-6 Text en © Torres-Perez et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Study Protocol
Torres-Perez, Elena
Valero, Monica
Garcia-Rodriguez, Beatriz
Gonzalez-Irazabal, Yolanda
Calmarza, Pilar
Calvo-Ruata, Luisa
Ortega, Carmen
Garcia-Sobreviela, Maria Pilar
Sanz-Paris, Alejandro
Artigas, Jose Maria
Lagos, Javier
Arbones-Mainar, Jose M
The FAT expandability (FATe) Project: Biomarkers to determine the limit of expansion and the complications of obesity
title The FAT expandability (FATe) Project: Biomarkers to determine the limit of expansion and the complications of obesity
title_full The FAT expandability (FATe) Project: Biomarkers to determine the limit of expansion and the complications of obesity
title_fullStr The FAT expandability (FATe) Project: Biomarkers to determine the limit of expansion and the complications of obesity
title_full_unstemmed The FAT expandability (FATe) Project: Biomarkers to determine the limit of expansion and the complications of obesity
title_short The FAT expandability (FATe) Project: Biomarkers to determine the limit of expansion and the complications of obesity
title_sort fat expandability (fate) project: biomarkers to determine the limit of expansion and the complications of obesity
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409987/
https://www.ncbi.nlm.nih.gov/pubmed/25896263
http://dx.doi.org/10.1186/s12933-015-0203-6
work_keys_str_mv AT torresperezelena thefatexpandabilityfateprojectbiomarkerstodeterminethelimitofexpansionandthecomplicationsofobesity
AT valeromonica thefatexpandabilityfateprojectbiomarkerstodeterminethelimitofexpansionandthecomplicationsofobesity
AT garciarodriguezbeatriz thefatexpandabilityfateprojectbiomarkerstodeterminethelimitofexpansionandthecomplicationsofobesity
AT gonzalezirazabalyolanda thefatexpandabilityfateprojectbiomarkerstodeterminethelimitofexpansionandthecomplicationsofobesity
AT calmarzapilar thefatexpandabilityfateprojectbiomarkerstodeterminethelimitofexpansionandthecomplicationsofobesity
AT calvoruataluisa thefatexpandabilityfateprojectbiomarkerstodeterminethelimitofexpansionandthecomplicationsofobesity
AT ortegacarmen thefatexpandabilityfateprojectbiomarkerstodeterminethelimitofexpansionandthecomplicationsofobesity
AT garciasobrevielamariapilar thefatexpandabilityfateprojectbiomarkerstodeterminethelimitofexpansionandthecomplicationsofobesity
AT sanzparisalejandro thefatexpandabilityfateprojectbiomarkerstodeterminethelimitofexpansionandthecomplicationsofobesity
AT artigasjosemaria thefatexpandabilityfateprojectbiomarkerstodeterminethelimitofexpansionandthecomplicationsofobesity
AT lagosjavier thefatexpandabilityfateprojectbiomarkerstodeterminethelimitofexpansionandthecomplicationsofobesity
AT arbonesmainarjosem thefatexpandabilityfateprojectbiomarkerstodeterminethelimitofexpansionandthecomplicationsofobesity
AT torresperezelena fatexpandabilityfateprojectbiomarkerstodeterminethelimitofexpansionandthecomplicationsofobesity
AT valeromonica fatexpandabilityfateprojectbiomarkerstodeterminethelimitofexpansionandthecomplicationsofobesity
AT garciarodriguezbeatriz fatexpandabilityfateprojectbiomarkerstodeterminethelimitofexpansionandthecomplicationsofobesity
AT gonzalezirazabalyolanda fatexpandabilityfateprojectbiomarkerstodeterminethelimitofexpansionandthecomplicationsofobesity
AT calmarzapilar fatexpandabilityfateprojectbiomarkerstodeterminethelimitofexpansionandthecomplicationsofobesity
AT calvoruataluisa fatexpandabilityfateprojectbiomarkerstodeterminethelimitofexpansionandthecomplicationsofobesity
AT ortegacarmen fatexpandabilityfateprojectbiomarkerstodeterminethelimitofexpansionandthecomplicationsofobesity
AT garciasobrevielamariapilar fatexpandabilityfateprojectbiomarkerstodeterminethelimitofexpansionandthecomplicationsofobesity
AT sanzparisalejandro fatexpandabilityfateprojectbiomarkerstodeterminethelimitofexpansionandthecomplicationsofobesity
AT artigasjosemaria fatexpandabilityfateprojectbiomarkerstodeterminethelimitofexpansionandthecomplicationsofobesity
AT lagosjavier fatexpandabilityfateprojectbiomarkerstodeterminethelimitofexpansionandthecomplicationsofobesity
AT arbonesmainarjosem fatexpandabilityfateprojectbiomarkerstodeterminethelimitofexpansionandthecomplicationsofobesity